Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Cloning: A Stem Cell Revolution?

The promise of stem cells, along with the controversy surrounding it, has made the industry a hot-button issue for many. Despite that promise, we have yet to see huge applicable benefits to humans. That could be changing. Cloning embryonic stem cells could mark a dramatic shift and improve on what is already a nascent process.

In this video, health-care analyst David Williamson discusses this breakthrough and what it means for investors interested in stem cell stocks.

Another topic health-care investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 

Read/Post Comments (2) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 19, 2013, at 1:52 PM, NanoORBust wrote:

    Pluristem (PSTI) uses Placenta stem cells like Celgene (CELG) and has just finished occupying a manufacturing plant for their patented 3D Bio-reactor. They have a specially designed method of transport for the cells. Their agreement with UTHR adds validity. They have a decent cash status after raising funds at $4.00 last year. All for a microcap of less than 200 million. Thinly traded but you can purchase at a discount to what the big boys paid.

  • Report this Comment On May 20, 2013, at 1:02 PM, PharmTeam wrote:

    It's important to remember that obtaining stem cells, be it from embryos our by inducing pluripotency, is not the exciting technology here. The differentiation of these cells into viable tissue is the real challenge. That's the real jackpot.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2439867, ~/Articles/ArticleHandler.aspx, 10/1/2016 1:38:45 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 16 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 3:59 PM
CUR $0.32 Up +0.00 +0.53%
Neuralstem CAPS Rating: ***
PSTI $1.60 Up +0.05 +3.23%
Pluristem Therapeu… CAPS Rating: *
STEM $1.36 Down -0.01 -0.73%
StemCells CAPS Rating: *